Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.19.3
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Total revenues $ 20,857 $ 4,865 $ 43,888 $ 6,652
Costs and expenses:        
Cost of product sales 310 69 728 99
Research and development 14,463 11,097 38,638 33,136
Selling, general and administrative 18,121 18,069 56,276 48,632
Total costs and expenses 32,894 29,235 95,642 81,867
Loss from operations (12,037) (24,370) (51,754) (75,215)
Interest income 555 604 2,068 1,507
Interest expense (8)   (8)  
Net loss $ (11,490) $ (23,766) $ (49,694) $ (73,708)
Net loss per share, basic and diluted (in dollars per share) $ (0.07) $ (0.14) $ (0.30) $ (0.47)
Weighted average shares used in computing net loss per share, basic and diluted (in shares) 167,609 166,464 167,326 158,456
Product sales, net        
Total revenues $ 11,716 $ 4,865 $ 29,943 $ 6,652
Contract revenues from collaborations        
Total revenues $ 9,141   $ 13,945